Two new (
1 and
2) and one known phenazine derivative (lavanducyanin,
3) were isolated and identified from the fermentation broth of a marine-derived
Streptomyces sp. (strain CNS284). In mammalian cell culture studies, compounds
1,
2 and
3 inhibited TNF-α-induced
[...] Read more.
Two new (
1 and
2) and one known phenazine derivative (lavanducyanin,
3) were isolated and identified from the fermentation broth of a marine-derived
Streptomyces sp. (strain CNS284). In mammalian cell culture studies, compounds
1,
2 and
3 inhibited TNF-α-induced NFκB activity (IC
50 values of 4.1, 24.2, and 16.3 μM, respectively) and LPS-induced nitric oxide production (IC
50 values of >48.6, 15.1, and 8.0 μM, respectively). PGE
2 production was blocked with greater efficacy (IC
50 values of 7.5, 0.89, and 0.63
μM, respectively), possibly due to inhibition of cyclooxygenases in addition to the expression of COX-2. Treatment of cultured HL-60 cells led to dose-dependent accumulation in the subG1 compartment of the cell cycle, as a result of apoptosis. These data provide greater insight on the biological potential of phenazine derivatives, and some guidance on how various substituents may alter potential anti-inflammatory and anti-cancer effects.
Full article